E
Vivos Therapeutics, Inc. VVOS
$2.15 $0.020.94% NASDAQ
Recommendation
Prev Close
$2.13
Volume
19,899
Avg Vol (90D)
243,483
Market Cap
$19.14M
Dividend & Yield
--
52-Week Range
$1.98 - $7.95
P/E (TTM)
--
EPS (TTM)
-$1.88
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Vivos Therapeutics Inc (VVOS) Q3 2025 Earnings Call Highlights: Revenue Surge Amid Strategic ...
11/27/2025 - GuruFocus
Q3 2025 Vivos Therapeutics Inc Earnings Call Transcript
11/26/2025 - GuruFocus
Vivos Therapeutics (VVOS) Sees Significant Revenue Growth in Q3 2025
11/20/2025 - GuruFocus
Vivos Therapeutics signals continued revenue acceleration amid SCN integration and SAMC expansion plans
11/20/2025 - SeekingAlpha.com: All News
Vivos Therapeutics, Inc. (VVOS) Q3 2025 Earnings Call Transcript
11/20/2025 - SeekingAlpha
Vivos Therapeutics, Inc. (VVOS) Q3 2025 Earnings Call Transcript
11/20/2025 - Seeking Alpha: Transcripts
Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025
11/19/2025 - GuruFocus
Vivos Therapeutics (VVOS) Achieves Significant Revenue Growth in Q3
11/19/2025 - GuruFocus
Vivos Therapeutics reports Q3 EPS (49c), consensus (51c)
11/19/2025 - The Fly
Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025
11/19/2025 - Globe Newswire
Vivos Therapeutics Schedules Release of Third Quarter 2025 Financial Results and Conference Call
11/19/2025 - GuruFocus
Vivos Therapeutics Schedules Release of Third Quarter 2025 Financial Results and Conference Call
11/19/2025 - Globe Newswire
Vivos Therapeutics (VVOS) Receives New Coverage From HC Wainwright VVOS Stock News
11/17/2025 - GuruFocus
Vivos Therapeutics initiated with a Buy at H.C. Wainwright
11/17/2025 - TipRanks Financial Blog
Vivos Therapeutics initiated with bullish view at H.C. Wainwright, here's why
11/17/2025 - The Fly
Vivos Therapeutics Delays Q3 Report Amid Acquisition
11/14/2025 - TipRanks Financial Blog
ARS Pharmaceuticals, Inc. (SPRY) Reports Q3 Loss, Beats Revenue Estimates
11/10/2025 - Zacks Investment Research
Aclaris Therapeutics (ACRS) Reports Q3 Loss, Tops Revenue Estimates
11/6/2025 - Zacks Investment Research
Vivos Therapeutics, Inc. (VVOS) Shareholder/Analyst Call Prepared Remarks Transcript
11/4/2025 - Seeking Alpha: Transcripts
Vivos Therapeutics, Inc. (VVOS) Shareholder/Analyst Call Prepared Remarks Transcript
11/4/2025 - SeekingAlpha
Zoetis (ZTS) Surpasses Q3 Earnings Estimates
11/4/2025 - Zacks Investment Research
Look Under The Hood: DFAC Has 14% Upside
10/17/2025 - ETF Channel
Vivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ...
9/30/2025 - GuruFocus
Vivos Therapeutics announces additional data from use of Vivos DNA device
9/30/2025 - The Fly
Vivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ADHD from Use of Vivos DNA Device
9/30/2025 - Globe Newswire
Income Statement
Total Revenue (TTM)
$17.32M
EBITDA (TTM)
-$15.31M
EBIT (TTM)
-$16.32M
Net Income (TTM)
-$17.10M
Balance Sheet
Total Assets (Q)
$25.64M
Total Debt (Q)
$12.50M
Total Liabilities (Q)
$23.11M
Book Value Per Share (Q)
$0.3063
Cash Flow
Cash from Operations (TTM)
-$14.39M
Cash from Investing (TTM)
-$6.11M
Cash from Financing (TTM)
$17.28M
Net Change in Cash (TTM)
-$3.22M
Filings
Filing Date
Wednesday, November 19, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
End of March (est)
Price History
Loading...
Beta
1.51
7-Day Total Return
1.42%
30-Day Total Return
-24.56%
60-Day Total Return
-43.86%
90-Day Total Return
-58.97%
Year to Date Total Return
-49.41%
1-Year Total Return
-41.26%
2-Year Total Return
-86.40%
3-Year Total Return
-82.08%
5-Year Total Return
-99.04%
52-week Low
Apr 17, 2025 - $1.98
52-week High
Jul 11, 2025 - $7.95
Valuation
Market Cap
$19.14M - Nano Cap
Enterprise Value
$28.56M
Price/Sales (TTM)
1.35
Price/Book (Q)
6.95
Dividends and Shares
Shares Outstanding
10.96
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.vivos.com
Phone Number
844 672 4357
Address
7921 Southpark Plaza
Littleton, CO 80120
Country
United States
Year Founded
2016
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA)... more
NASDAQ 12/02/2025 10:17AM Eastern Quotes delayed